Parr Mcknight Wealth Management Group LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 11.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,768 shares of the healthcare conglomerate's stock after selling 2,686 shares during the period. UnitedHealth Group makes up approximately 1.6% of Parr Mcknight Wealth Management Group LLC's holdings, making the stock its 8th biggest holding. Parr Mcknight Wealth Management Group LLC's holdings in UnitedHealth Group were worth $10,877,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of UNH. Norges Bank acquired a new stake in UnitedHealth Group during the fourth quarter worth about $6,375,744,000. GAMMA Investing LLC increased its stake in UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after acquiring an additional 8,280,404 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of UnitedHealth Group by 36.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after buying an additional 2,301,010 shares in the last quarter. Northern Trust Corp grew its position in shares of UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after buying an additional 1,058,488 shares in the last quarter. Finally, Capital International Investors boosted its position in shares of UnitedHealth Group by 6.2% during the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after acquiring an additional 906,365 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In related news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the purchase, the director owned 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have bought 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.28% of the company's stock.
Analyst Ratings Changes
UNH has been the subject of a number of analyst reports. Royal Bank Of Canada cut their target price on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. Erste Group Bank cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. Morgan Stanley lowered their price objective on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. HSBC reissued a "reduce" rating and issued a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Finally, Truist Financial restated a "buy" rating and issued a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $415.00.
Check Out Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Stock Up 0.7%
UnitedHealth Group stock traded up $2.07 during trading hours on Friday, reaching $301.58. The stock had a trading volume of 5,787,602 shares, compared to its average volume of 7,655,490. The company has a market cap of $273.57 billion, a price-to-earnings ratio of 12.61, a PEG ratio of 1.45 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The business's 50 day moving average price is $316.42 and its 200-day moving average price is $442.28. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the previous year, the firm posted $6.91 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.93%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report